How many institutions held VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in Q3 2018?

45 institutional investors reported VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value for Q3 2018. Use the holders table for investor-level position and value details.

Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)

Q: What does CUSIP 92511W108 represent in this 13F holders report?

CUSIP 92511W108 is the security identifier for VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

CUSIP: 92511W108

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 92,448,158
Total 13F shares: 8,239,628
Share change: -75,045
Total reported value: $133,896,000
Price per share: $16.25
Number of holders: 45
Value change: -$2,329,398
Number of buys: 33
Number of sells: 14

Quarterly Holders Quick Answers

What is CUSIP 92511W108?
CUSIP 92511W108 identifies VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2018
Previous quarter: Q2 2018

Recent filing periods for CUSIP 92511W108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13F	Company	3.7%	3,410,412	$67,287,000	—	30 Jun 2018	13F
ORBIMED ADVISORS LLC	13F	Company	1.6%	1,479,733	$29,195,000	—	30 Jun 2018	13F
FMR LLC	13F	Company	1.2%	1,100,000	$21,703,000	—	30 Jun 2018	13F
Fosun International Ltd	13F	Company	0.86%	795,999	$15,705,000	—	30 Jun 2018	13F
FIL Ltd	13F	Company	0.45%	417,594	$8,239,000	—	30 Jun 2018	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.16%	149,044	$2,941,000	—	30 Jun 2018	13F
KORNITZER CAPITAL MANAGEMENT INC /KS	13F	Company	0.16%	147,235	$2,905,000	—	30 Jun 2018	13F
CONNING INC.	13F	Company	0.14%	130,733	$2,579,000	—	30 Jun 2018	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.14%	125,800	$2,482,000	—	30 Jun 2018	13F
Alyeska Investment Group, L.P.	13F	Company	0.08%	70,048	$1,382,000	—	30 Jun 2018	13F
Asymmetry Capital Management, L.P.	13F	Company	0.06%	60,000	$1,184,000	—	30 Jun 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.05%	50,714	$1,001,000	—	30 Jun 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.04%	40,284	$795,000	—	30 Jun 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.04%	39,289	$772,000	—	30 Jun 2018	13F
DC Investments Management, LLC	13F	Company	0.04%	34,286	$676,000	—	30 Jun 2018	13F
NORGES BANK	13F	Company	0.03%	30,000	$592,000	—	30 Jun 2018	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.03%	30,000	$592,000	—	30 Jun 2018	13F
VANGUARD GROUP INC	13F	Company	0.03%	27,838	$549,000	—	30 Jun 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.03%	25,749	$508,000	—	30 Jun 2018	13F
Laurion Capital Management LP	13F	Company	0.02%	20,000	$395,000	—	30 Jun 2018	13F
BlueCrest Capital Management Ltd	13F	Company	0.02%	15,000	$296,000	—	30 Jun 2018	13F
Capital Investment Advisory Services, LLC	13F	Company	0.01%	10,700	$211,000	—	30 Jun 2018	13F
MORGAN STANLEY	13F	Company	0%	2,407	$47,000	—	30 Jun 2018	13F
ROYAL BANK OF CANADA	13F	Company	0%	1,270	$25,000	—	30 Jun 2018	13F
Catalyst Capital Advisors LLC	13F	Company	0%	285	$6,000	—	30 Jun 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	146	$3,000	—	30 Jun 2018	13F
UBS Group AG	13F	Company	0%	107	$2,000	—	30 Jun 2018	13F

Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q3 2018

As of 30 Sep 2018, Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,239,628 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Fosun International Ltd, FMR LLC, Vanguard Group Inc, BlackRock Inc., KORNITZER CAPITAL MANAGEMENT INC /KS, FIL Ltd, GILDER GAGNON HOWE & CO LLC, and CONNING INC.. This page lists 45 institutional shareholders reporting positions in this security for the Q3 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders

Q3 2018 holders

Holder diff

Investor	Q2 2018 Shares	Q3 2018 Shares	Share Diff	Share Chg %	Q2 2018 Value $	Q3 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.